Results 181 to 190 of about 30,793 (265)

Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade. [PDF]

Int J Mol Sci
Demircan T, Yıldırım B, Ünsal Hİ, Bilir A.   +3 more
europepmc   +1 more source

An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres

Medical Journal of Australia, Volume 224, Issue 11, November 2026.
ABSTRACT Adoptive cellular therapies (ACT), including tumour‐infiltrating lymphocyte (TIL), T‐cell receptor‐engineered T (TCR‐T) cell and chimeric antigen receptor T‐cell (CAR‐T) therapies, represent an evolving class of immunotherapies with established efficacy in selected haematological malignancies and emerging applications in solid tumours ...
Sarah Childs, David Ma, Anthony Rodrigues, Jennifer Massey, Rasha Cosman, Venessa Chin, Laila Girgis, James Lynam, Peter Lau, Barbara Withers, Anthony M. Joshua, Ben Tran, Jayesh Desai, Simon J. Harrison, John Moore, Jia Liu   +15 more
wiley   +1 more source

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy. [PDF]

Exp Mol Med
Cho S, Lee J, Lee YM, Nam JH.
europepmc   +1 more source

Neoantigen Peptide [PDF]

, 2020
openaire   +1 more source

Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer. [PDF]

Sci Adv
Zhang Perkins F, Zhang X, Yu YYL, Yang Y, Cullinan D, Singhal K, Parra-Lopez CA, Miller CA, Yan B, Angkeow JW, Li J, Myers NB, Vickery T, Herndon J, Mishra R, Myles S, Sanford D, Jaffee EM, Laheru DA, Wang-Gillam A, Ruzinova MB, Hagemann IS, Davies SR, Fleming TP, Namen S, DeSelm CJ, Li L, Panni RZ, Gao F, Lim KH, Griffith OL, Griffith M, Schreiber RD, Goedegebuure SP, Hawkins WG, Gillanders WE.   +35 more
europepmc   +1 more source

Autoimmunity: the neoantigen hypothesis

Frontiers in Immunology
Tomas Mustelin, Felipe Andrade
openaire   +3 more sources

Correction to "A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor". [PDF]

J Oncol
europepmc   +1 more source

Artificial intelligence for translational personalized neoantigen cancer vaccine development. [PDF]

J Biomed Sci
Wei CY, Lin HC, Wu CJ, Kuo CN, Chang CM, Chou WH, Chou SP, Feng SH, Huang WC, Jiang S, Fairfax BP, Lee KY, Chang WC.   +12 more
europepmc   +1 more source

Recent Advances in Lipid Nanoparticles for Cancer Vaccines: From Antigen Delivery to Personalized Immunotherapy. [PDF]

Int J Mol Sci
Rachamala HK, Angom RS, Marepally S.
europepmc   +1 more source

Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors. [PDF]

Immunity
Borden ES, Castellano D, Kantzos EA, Hughes A, Leibovit-Reiben Z, Stockard A, Choudhary A, Ma T, Li X, Mangold AR, Gutenkunst RN, LaFleur BJ, Buetow KH, Wilson MA, Hastings KT.   +14 more
europepmc   +1 more source